Journal
JOURNAL OF NANOPARTICLE RESEARCH
Volume 12, Issue 5, Pages 1599-1608Publisher
SPRINGER
DOI: 10.1007/s11051-009-9681-3
Keywords
Iron oxide; Nanoparticles; Bombesin; Prostate cancer; Magnetic resonance imaging; Nanomedicine
Categories
Funding
- Ontario Institute for Cancer Research
- Canadian Institutes of Health [MOP-84535]
Ask authors/readers for more resources
The imaging of molecular markers associated with disease offers the possibility for earlier detection and improved treatment monitoring. Receptors for gastrin-releasing peptide are overexpressed on prostate cancer cells offering a promising imaging target, and analogs of bombesin, an amphibian tetradecapeptide have been previously demonstrated to target these receptors. Therefore, the pan-bombesin analog [beta-Ala11, Phe13, Nle14]bombesin-(7-14) was conjugated through a linker to dye-functionalized superparamagnetic iron oxide nanoparticles for the development of a new potential magnetic resonance imaging probe. The peptide was conjugated via click chemistry, demonstrating a complementary alternative methodology to conventional peptide-nanoparticle conjugation strategies. The peptide-functionalized nanoparticles were then demonstrated to be selectively taken up by PC-3 prostate cancer cells relative to unfunctionalized nanoparticles and this uptake was inhibited by the presence of free peptide, confirming the specificity of the interaction. This study suggests that these nanoparticles have the potential to serve as magnetic resonance imaging probes for the detection of prostate cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available